Suppressor of cytokine signaling 2 (SOCS2) associates with FLT3 and negatively regulates downstream signaling

The suppressor of cytokine signaling 2 (SOCS2) is a member of the SOCS family of E3 ubiquitin ligases. SOCS2 is known to regulate signal transduction by cytokine receptors and receptor tyrosine kinases. The receptor tyrosine kinase FLT3 is of importance for proliferation, survival and differentiation of hematopoietic cells and is frequently mutated in acute myeloid leukemia. We observed that SOCS2 associates with activated FLT3 through phosphotyrosine residues 589 and 919, and co‐localizes with FLT3 in the cell membrane. SOCS2 increases FLT3 ubiquitination and accelerates receptor degradation in proteasomes. SOCS2 negatively regulates FLT3 signaling by blocking activation of Erk 1/2 and STAT5. Furthermore, SOCS2 expression leads to a decrease in FLT3‐ITD‐mediated cell proliferation and colony formation. Thus, we suggest that SOCS2 associates with activated FLT3 and negatively regulates the FLT3 signaling pathways.

[1]  Kristina Masson,et al.  A role of Gab2 association in Flt3 ITD mediated Stat5 phosphorylation and cell survival , 2009, British journal of haematology.

[2]  K. Okkenhaug,et al.  Socs1 binds to multiple signalling proteins and suppresses Steel factor‐dependent proliferation , 1999, The EMBO journal.

[3]  S. Horvat,et al.  Lack of Socs2 expression causes the high-growth phenotype in mice. , 2001, Genomics.

[4]  L. Ashman,et al.  Src Family Kinases Are Involved in the Differential Signaling from Two Splice Forms of c-Kit* , 2003, The Journal of Biological Chemistry.

[5]  E. Heiss,et al.  Identification of Y 589 and Y 599 in the juxtamembrane domain of Flt 3 as ligand-induced autophosphorylation sites involved in binding of Src family kinases and the protein tyrosine phosphatase SHP 2 , 2006 .

[6]  I. Wistuba,et al.  STAT5A-Mediated SOCS2 Expression Regulates Jak2 and STAT3 Activity Following c-Src Inhibition in Head and Neck Squamous Carcinoma , 2011, Clinical Cancer Research.

[7]  C. Wernstedt,et al.  Mutation of a Src phosphorylation site in the PDGF beta‐receptor leads to increased PDGF‐stimulated chemotaxis but decreased mitogenesis. , 1996, The EMBO journal.

[8]  D. Schmidt-Arras,et al.  Anchoring of FLT3 in the endoplasmic reticulum alters signaling quality. , 2009, Blood.

[9]  M. Levis,et al.  FLT3: ITDoes matter in leukemia , 2003, Leukemia.

[10]  W. Hiddemann,et al.  Overexpression and constitutive activation of FLT3 induces STAT5 activation in primary acute myeloid leukemia blast cells. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[11]  Bengt Phung,et al.  Suppressor of Cytokine Signaling 6 (SOCS6) Negatively Regulates Flt3 Signal Transduction through Direct Binding to Phosphorylated Tyrosines 591 and 919 of Flt3* , 2012, The Journal of Biological Chemistry.

[12]  C. Heldin,et al.  Increased Kit/SCF receptor induced mitogenicity but abolished cell motility after inhibition of protein kinase C. , 1993, The EMBO journal.

[13]  J. Goncalves,et al.  Phosphorylation of a novel SOCS-box regulates assembly of the HIV-1 Vif-Cul5 complex that promotes APOBEC3G degradation. , 2004, Genes & development.

[14]  R. Frank,et al.  Suppressor of Cytokine Signaling 6 Associates with KIT and Regulates KIT Receptor Signaling* , 2004, Journal of Biological Chemistry.

[15]  Claes Ohlsson,et al.  SOCS2 negatively regulates growth hormone action in vitro and in vivo. , 2005, The Journal of clinical investigation.

[16]  J. Johnston,et al.  Tyrosine-phosphorylated SOCS-3 inhibits STAT activation but binds to p120 RasGAP and activates Ras , 2001, Nature Cell Biology.

[17]  Chunaram Choudhary,et al.  Activation mechanisms of STAT5 by oncogenic Flt3-ITD. , 2006, Blood.

[18]  S. Knapp,et al.  Structural Basis for c-KIT Inhibition by the Suppressor of Cytokine Signaling 6 (SOCS6) Ubiquitin Ligase* , 2010, The Journal of Biological Chemistry.

[19]  宁北芳,et al.  疟原虫var基因转换速率变化导致抗原变异[英]／Paul H, Robert P, Christodoulou Z, et al//Proc Natl Acad Sci U S A , 2005 .

[20]  M. L. Nielsen,et al.  The SOCS2 Ubiquitin Ligase Complex Regulates Growth Hormone Receptor Levels , 2011, PloS one.

[21]  S. Gery,et al.  Adaptor protein Lnk binds to and inhibits normal and leukemic FLT3. , 2012, Blood.

[22]  Masato Kubo,et al.  SOCS proteins, cytokine signalling and immune regulation , 2007, Nature Reviews Immunology.

[23]  Kristina Masson,et al.  Oncogenic signaling from the hematopoietic growth factor receptors c-Kit and Flt3. , 2009, Cellular signalling.

[24]  P. Lawrence,et al.  Genes in development , 1977, Nature.

[25]  Kristina Masson,et al.  Oncogenic Flt3 receptors display different specificity and kinetics of autophosphorylation. , 2009, Experimental hematology.

[26]  J. Johnston,et al.  Tyrosine Phosphorylation Disrupts Elongin Interaction and Accelerates SOCS3 Degradation* , 2003, Journal of Biological Chemistry.

[27]  R. Geffers,et al.  SOCS2: inhibitor of JAK2V617F-mediated signal transduction , 2008, Leukemia.

[28]  L. Rönnstrand,et al.  FLT3 signals via the adapter protein Grb10 and overexpression of Grb10 leads to aberrant cell proliferation in acute myeloid leukemia , 2013, Molecular oncology.

[29]  E. Heiss,et al.  Identification of Y589 and Y599 in the juxtamembrane domain of Flt3 as ligand-induced autophosphorylation sites involved in binding of Src family kinases and the protein tyrosine phosphatase SHP2. , 2006, Blood.

[30]  U. Hellman,et al.  Identification of Tyr900 in the kinase domain of c-Kit as a Src-dependent phosphorylation site mediating interaction with c-Crk. , 2003, Experimental cell research.

[31]  L. Rönnstrand,et al.  Src-Like Adaptor Protein (SLAP) Binds to the Receptor Tyrosine Kinase Flt3 and Modulates Receptor Stability and Downstream Signaling , 2012, PloS one.

[32]  Chunaram Choudhary,et al.  SOCS1 cooperates with FLT3-ITD in the development of myeloproliferative disease by promoting the escape from external cytokine control. , 2010, Blood.

[33]  C. Ohlsson,et al.  SOCS 2 negatively regulates growth hormone action in vitro and in vivo , 2005 .

[34]  Stefan Knapp,et al.  Crystal structure of the SOCS2–elongin C–elongin B complex defines a prototypical SOCS box ubiquitin ligase , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[35]  J. Aliberti,et al.  SOCS2-Induced Proteasome-Dependent TRAF6 Degradation: A Common Anti-Inflammatory Pathway for Control of Innate Immune Responses , 2012, PloS one.

[36]  M. Nawijn,et al.  Pim serine/threonine kinases regulate the stability of Socs-1 protein , 2002, Proceedings of the National Academy of Sciences of the United States of America.